HHS unveils ARPA-H SURPASS program to accelerate clinical trial design
The U.S. Department of Health and Human Services announced a new initiative under ARPA-H called the Simulation‑augmented, Real‑time Platform Adaptive Seamless Trials (SURPASS) program.
SURPASS is intended to modernize clinical trial design by using simulation and real‑time data integration to create adaptive, seamless study protocols.
By streamlining trial processes, the program aims to reduce development timelines and bring medical products to market more quickly.
The funding opportunity will support collaborations between government, academia, and industry to develop and test these new trial platforms.
This writeup was produced by pharmadog from original reporting by raps.
Original headline: “HHS launches ARPA-H project to speed clinical trials”
read at raps ↗
comments(0)
5-min edit window · permanent after that